For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Researchers using next-generation DNA sequencing have identified four specific genes whose mutations are linked to the ...

Four specific genes serve as a telltale clue to how potentially deadly stomach cancers will develop and progress, a new study ...

That condition puts her at an 80% chance of developing stomach cancer and a 60% chance of developing breast cancer. Surgery nightmare: Hospital admits mistake after failed cancer surgery attempt ...

Socially vulnerable and minority patients are less likely to receive guideline-concordant care ... New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable ...

Kase serves on the NCCN Head and Neck Cancer Guidelines Panel which writes guidelines used worldwide to treat head and neck cancer patients.

Over 90% of patients with metastatic pancreatic cancer achieved at least one indicator of guideline-concordant care. The percentage of patients achieving at least one quality indicator has ...

Sidney Raz, known for his popular 'Life Hacks' series, learned he had stomach cancer despite having no symptoms Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously appeared in ...

Findings from the DESTINY-Gastric03 study support the further exploration of the antibody-drug conjugate trastuzumab deruxtecan for the first-line treatment of patients with advanced HER2+ gastric, ...

HLX22 received orphan drug designation, offering incentives like tax credits and market exclusivity to accelerate development for gastric cancer treatment. Phase 2 trial results showed HLX22 improved ...

uniklinikum-dresden.de Objective Gastric cancer is the second leading cause of cancer-related deaths and the fifth most common malignancy worldwide. In this study, human and mouse gastric cancer ...

The workshop discussions were focused on five major topics: (1) genetic counselling and mutation analysis; (2) endoscopic surveillance and screening of cancer; (3) risk-reduction surgery of the ...